6541 — Tanvex Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Tanvex Biopharma, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,427	2,069	2,226	786	381
Net Total Accounts Receivable
Net Total Receivables	1.29	1.91	0.36	2.76	10.4
Total Inventory
Prepaid Expenses
Total Current Assets	2,605	2,264	2,402	1,044	604
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	923	1,906	2,114	2,151	1,928
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,573	4,373	4,714	3,420	2,763
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	270	353	249	303	364
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	542	1,752	1,919	2,028	1,942
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3,031	2,621	2,795	1,391	821
Total Liabilities & Shareholders' Equity	3,573	4,373	4,714	3,420	2,763
Total Common Shares Outstanding